Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 20,000 shares at $13.00 ($260K) on 2021-09-24, disclosed to the SEC on 2021-09-24.
Open-market sale of $260k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KDNY | SELL | 2023-02-02 | $225K | — | Filing → |
| KDNY | SELL | 2022-12-15 | $250K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |